四維圖新(002405.SZ):第一大股東擬協議轉讓6.23%公司股份
格隆匯8月26日丨四維圖新(002405.SZ)公佈,公司於2022年8月25日收到公司第一大股東中國四維測繪技術有限公司(以下簡稱"中國四維")通知,根據有關規定,中國四維因改革發展需要,以及為支持上市公司長遠發展考慮,擬通過公開徵集轉讓方式協議轉讓其持有的公司147,843,309股股份,佔公司2022年6月30日總股本的比例為6.23%。
截至公吿披露日,中國四維持有公司195,278,651股,均為無限售條件股份,佔公司2022年6月30日總股本的比例為8.23%,為公司第一大股東。公司為無控股股東、無實際控制人的上市公司。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.